Effectiveness of an mHealth Intervention, Based on Rehabilitation and a Personalised Nutrition Plan, in the Recovery and Improvement of Dysphagia in Patients Diagnosed With Stroke

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Cadiz

About this trial

The goal of this clinical trial is to evaluate the efficacy of an mHealth intervention as a complement to usual clinical practice for the improvement and recovery of dysphagia in patients who have suffered a stroke. The main question it aims to answer is:

\- Does the mHealth intervention improve the recovery of dysphagia in post-stroke patients compared to usual care alone?

Researchers will compare patients receiving the mHealth intervention plus usual care to see if the combined approach leads to better dysphagia outcomes, reduced negative consequences (e.g., malnutrition, pneumonia), and improved quality of life compared to usual care alone.

Participants will be recruited and:

* Receive a diagnosis and usual care for post-stroke dysphagia. * Be assigned to either the mHealth intervention group (using a smartphone/tablet app for information and follow-up) or the control group (usual care only). * Be followed up to assess dysphagia recovery, reduction in negative outcomes (like aspiration pneumonia, dehydration), and changes in quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects aged 18 years or older.

Patients with any degree of impairment in swallowing/oropharyngeal dysphagia to liquids following a stroke (ACV).

Disqualifiers

Hospitalized patients presenting any type of visual barrier.

Patients in terminal palliative care.

Patients in the final days of life phase.

Patients with severe cognitive impairment.

Trial design

Design model

Parallel

Treatments tested in this trial

  • mHealth intervention

    Other intervention

    The intervention consists of using the validated mobile application "DegluApp", which contains recommendations and exercises related to nutrition, physical activity, rehabilitation, warning signs, and games pertinent to the daily life of a person with post-stroke dysphagia.

Treatment groups

74 Participants
are divided into 2 treatment groups
Group A: mHealth GroupExperimental treatment 1 intervention
Group B: No intervention GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Dysphagia Improvement and Recovery

Dysphagia Improvement and Recovery. Dichotomous qualitative variable: Yes, No.

Time frame
Day 1, 3 months, 6 months, and 9 months
2

Type of texture

Type of texture and volume the patient follows in their habitual diet. Categorical qualitative variable: Liquid, Nectar, Honey, Pudding.

Time frame
Day 1, 3 months, 6 months, and 9 months
3

Volume allowed when swallowing

Volume the patient follows in their habitual diet. Categorical qualitative variable: 5 mL, 10 mL, and 20 mL

Time frame
Day 1, 3 months, 6 months, and 9 months
4

Acceptable viscosity when swallowing

Measured using the Volume-Viscosity Swallow Test (V-VST). The test is performed using three different viscosities (thin liquid, nectar-thick, and pudding-thick) and three different volumes 3 ml, 5 ml, and 20 ml) to determine the volume-viscosity combination that is safest and most efficient for the patient. It is a clinical diagnostic tool used to evaluate the efficacy and safety of a patient's swallowing function (deglutition) by systematically challenging it with a controlled set of liquid volumes and viscosities. It contains two main safety and efficiency markers. For the Safety Scale (aspiration/penetration), levels typically range from a minimum of 0 (no safety issues detected) to a maximum of 2 (indicating severe issues like persistent cough or desaturation). Similarly, the Efficiency Scale might range from Level 0 (efficient swallow) to Level 1 (reduced efficiency).

Time frame
Day 1, 3 months, 6 months, and 9 months

Secondary outcomes

1

Perceived quality of life

Categorical qualitative variable: EuroQoL 5 Dimensions - 5 Levels (EuroQoL 5D-5L). They are scored using a 5-point Likert scale (1. No problem; 5. Unable). The sixth dimension scores ranging from 0 (worst health status) to 100 (best health status).

Time frame
Day 1, 3 months, 6 months, and 9 months
2

Weight

Continuous quantitative variable: kg.

Time frame
Day 1, 3 months, 6 months, and 9 months
3

Height

Continuous quantitative variable: cm.

Time frame
Day 1, 3 months, 6 months, and 9 months
4

Body Mass Index

Continuous quantitative variable: kg/m².

Time frame
Day 1, 3 months, 6 months, and 9 months

Other outcomes

1

Sex

Dichotomous qualitative variable: Female, Male.

Time frame
Day 1
2

Age

Discrete quantitative variable: years.

Time frame
Day 1
3

Presence of caregiver

Dichotomous qualitative variable: Yes, No.

Time frame
Day 1
4

Degree of dependence for performing Activities of Daily Living

Categorical qualitative variable: Barthel Index. It is a foundational ordinal scale used primarily in rehabilitation and geriatric medicine to measure a person's level of independence in activities of daily living (ADLs) and functional mobility. It assesses ten essential areas: feeding, bathing, grooming, dressing, bowel control, bladder control, toilet use, transfers (bed to chair), mobility (walking or wheelchair), and climbing stairs. The total score reflects the individual's ability to perform these tasks with or without assistance, providing a clear indication of their care needs and the effectiveness of rehabilitation interventions. The Barthel Index ranges from a minimum value of 0, which signifies a totally dependent state requiring maximum assistance in all activities, to a maximum value of 100, which indicates complete independence in all ten functional areas.

Time frame
Day 1, 3 months, 6 months, and 9 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Cadiz

Lead sponsor

Andalusian Health Service

Collaborator